CLBT
Cellebrite DI
NASDAQ: CLBT · TECHNOLOGY · SOFTWARE - INFRASTRUCTURE
$12.71
+0.24% today
Updated 2026-04-29
Market cap
$3.17B
P/E ratio
41.00
P/S ratio
6.67x
EPS (TTM)
$0.31
Dividend yield
—
52W range
$11 – $21
Volume
1.8M
WallStSmart proprietary scores
48
out of 100
Grade: C
Sell
Investment rating
7.3
Growth
B+5.8
Quality
C+7.5
Profitability
B+3.7
Valuation
D3/9
Piotroski F-Score
Weak
1.7
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$21.67
+70.50%
12-Month target
$9.30
-26.83%
Intrinsic (DCF)
$11.96
Margin of safety
-19.23%
2 Strong Buy5 Buy0 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Free cash flow $78.27M — positive
+ Revenue growth 18.10% QoQ
Risks
- Piotroski 3/9 — weak financial health
- Altman Z 1.71 — distress zone
- 19.23% above intrinsic value
- P/E 41.00x — expensive valuation
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $270.65M | $325.11M | $401.20M | $475.68M | $475.68M |
| Net income | $120.81M | $-81.10M | $-283.01M | $78.33M | $21.26M |
| EPS | — | — | — | — | $0.31 |
| Free cash flow | $11.49M | $94.14M | $121.56M | $155.73M | $78.27M |
| Profit margin | 44.63% | -24.95% | -70.54% | 16.47% | 16.50% |
Peer comparison
Smart narrative
Cellebrite DI trades at $12.71. representing a P/E of 41.00x trailing earnings. Our Smart Value Score of 48/100 indicates the stock is fair. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 1.71, it sits in the distress. TTM revenue stands at $475.68M. with profit margins at 16.50%. Our DCF model estimates intrinsic value at $11.96.
Frequently asked questions
What is Cellebrite DI's stock price?
Cellebrite DI (CLBT) trades at $12.71.
Is Cellebrite DI overvalued?
Smart Value Score 48/100 (Grade C, Sell). DCF value $11.96.
What is the price target of Cellebrite DI (CLBT)?
The analyst target price is $21.67, representing +70.5% upside from the current price of $12.71.
What is the intrinsic value of Cellebrite DI (CLBT)?
Based on our DCF model, intrinsic value is $11.96, a -19.2% margin of safety versus $12.71.
What is Cellebrite DI's revenue?
TTM revenue is $475.68M.
Piotroski F-Score?
3/9 — weak financial health.
Altman Z-Score?
1.71 — distress.
Company info
SectorTECHNOLOGY
IndustrySOFTWARE - INFRASTRUCTURE
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio6.67x
ROE19.10%
Beta1.28
50D MA$13.59
200D MA$15.98
Shares out0.25B
Float0.12B
Short ratio—
Avg volume1.8M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—